Nectar Lifesciences Limited Buyback
Nectar Lifesciences Buyback 2025
Tender Offer
₹27.00
Buyback price per shareAbout Nectar Lifesciences Limited Buyback
Nectar Lifesciences is a research-driven, fully integrated pharmaceutical company. Its core business revolves around the manufacturing of active pharmaceutical ingredients, mainly cephalosporin antibiotics and intermediates.
It has also ventured beyond APIs into contract manufacturing of FDFs/formulations such as tablets, capsules, suspensions, granules, and injectables. They also manufacture empty hard gelatin capsules (EHGCs) and have a presence in phytochemicals / menthol-based products.
The facilities of Nectar are state-of-the-art, comprising a total of 13 facilities across Punjab and Himachal Pradesh for oral and sterile drug productions, empty capsule production, and menthol or phytochemicals.
These plants meet the current global regulatory requirements for EHS/cGMP, besides approbations by the international regulatory authorities for export markets. This ensures that the quality of the product is guaranteed.
Nectar Lifesciences Limited Buyback Details
Security Name
Nectar Lifesciences LimitedBuyback Price
₹27.00Face Value
₹10.00Listing at Group
BSE, NSELead Manager
Master Capital Services Ltd.Buyback Docs
Letter Of OfferIssue Size
3,00,00,000 (13.38 % of Total number of equity Shares)Nectar Lifesciences Buyback 2025 Issue Timetable
| Last Date to buy shares | Record Date | Offer Opens On | Offer Closes On * |
| TBA | Dec 24, 2025 | TBA | TBA |
| Last Date for receipt of Tender Forms | Finalisation of Buyback Acceptance | Last Date for settlement of bids | Last Date for Extinguishment of Shares |
| TBA | TBA | TBA | TBA |
Nectar Lifesciences Limited Buyback Ratio
| Category | Entitlement Ratio of Buyback | Shares Offered |
| Reserved Category for Small Shareholders | / | |
| General Category for all other Eligible Shareholders | / |
Company Financials All values are in ₹ Cr.
| Period Ended | 31-Mar-24 | 31-Mar-23 |
|---|---|---|
| Profit After Tax | -- | -- |
| Total Borrowing | -- | -- |
| Total Assets | -- | -- |
| Reserves And Surplus | -- | -- |
| Total Revenue | -- | -- |
| Net Worth | -- | -- |
How to Participate in Nectar Lifesciences Limited Buyback?
1. Firstly, to be eligible for the buyback the investor should have shares of Nectar Lifesciences Limited Buyback in Demat or physical form as on the record date Dec 24, 2025.
2. Once you have shares in Demat, you can participate in the buyback process which is opening from TBA by tendering your shares through your broker on BSE, NSE.
3. Then on TBA, the payment will be given to you for accepted shares and unaccepted shares will be returned to your Demat account.
Calculation of Investment in Nectar Lifesciences Limited Buyback
|
Maximum market value of a share holder as on record date |
₹200,000.00 |
|
Buyback price per share |
₹27.00 |
|
Maximum share for small shareholders (200000/ 27) |
7407.41 share |
|
Closing price of stock as of 2025-12-03 |
₹17.92 |
|
Maximum amount insted in buyback (₹17.92 x 7407.407407407408 shares) |
₹132,740.74 |
* No. of shares stands to change according to the closing price on the record date
* For simplicity, we have considered the price on date Dec 3, 2025
Expected Profit from the Nectar Lifesciences Limited Buyback on the bases of acceptance Ratio:
|
Acceptance Ratio |
33% |
50% |
75% |
100% |
|
Amount Invested in Buyback |
₹132,740.74 |
₹132,740.74 |
₹132,740.74 |
₹132,740.74 |
|
No. of Shares Buyback |
2444 |
3703 |
5555 |
7407 |
|
Buyback Profit |
22191 |
33623 |
50439 |
67255 |
|
Profit% |
16.72% |
25.33% |
38.00% |
50.67% |
Nectar Lifesciences Limited Buyback - Necessity of the Objective
The buyback will help the company to return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
The buyback will help the company to optimize the capital structure;
The Buyback, which is being implemented through the Tender Offer route as prescribed under the SEBI Buyback Regulations, would involve allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved. The company believes that the reservation for small shareholders would benefit a large number of the Company's public shareholders, who get classified as small Shareholders, as per regulations 2(i)(n) of the SEBI Buyback Regulations.
The buyback may help in improving financial ratios like earnings per share, return on capital employed, and return on equity, by reduction in the equity base, thereby leading to long-term increase in shareholders' vlaue; and
The buyback gives an option to the shareholders holding Equity shares of the company, who can choose to participate and get cash in lieu of Equity shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the buyback offer, without additional investment.
Nectar Lifesciences Limited Buyback
Shop No. 5, SL Enclave, Behind Sohi HP Gas Agency, Barwala Road, Dera Bassi, Punjab, 140507Email: sales@neclife.com
Phone: +91-0172-5078200
Website: https://www.neclife.com/
Kfin Technologies Ltd.
Email: nectar.buyback@kfintech.com
Phone: 04067162222, 04079611000
Website: https://ipostatus.kfintech.com/
